GlaxoSmithKline Pharmaceuticals Ltd

Common Name

GlaxoSmithKline Pharmaceuticals

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

3,113

Ticker

GLAXO

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

india-pharma.gsk.com

Description

GlaxoSmithKline Pharmaceuticals Ltd. is a major player in the pharmaceutical industry, renowned for its development and manufacturing of a broad range of healthcare products. The company's primary foc... Show more

Financial Statements of GlaxoSmithKline Pharmaceuticals

Below are the financial statements of GlaxoSmithKline Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of INR	2025	2024
Non-current assets	—	—
Property, plant and equipment	2,602.92^a	2,793.59^a
Right of use assets	92.47^a	174.44^a
Capital work-in-progress	143.2^a	139.3^a
Investment property	7.83^a	9.18^a
Intangible assets	133.32^a	235.54^a
Financial assets	—	—
Loans	0^a	0^a
Other financial assets	114.97^a	102.18^a
Current tax assets (net)	1,959.99^a	2,136.38^a
Deferred tax assets (net)	1,408.66^a	1,463.12^a
Other non-current assets	518.49^a	528.27^a
Assets	—	—
Non-current assets	6,981.85^a	7,581.99^a
Current assets	—	—
Inventories	4,817.37^a	5,250.48^a
Financial assets	—	—
Current investments	11,182.46^a	8,132.23^a
Trade receivables	2,925.49^a	2,220.57^a
Cash and cash equivalents	5,388.48^a	641.71^a
Bank balances other than (iii) above	8,646.69^a	9,990.47^a
Other financial assets	707.8^a	1,301.43^a
Other current assets	430.52^a	447.29^a
Current assets	34,098.81^a	27,984.19^a
Total assets	41,080.66^a	35,566.18^a
Equity	—	—
Equity share capital	1,694.06^a	1,694.06^a
Other equity	17,819.05^a	16,082.34^a
Total equity	19,513.11^a	17,776.4^a
Financial liabilities	—	—
Lease liabilities	24.92^a	64.69^a
Other financial liabilities	0^a	0.98^a
Provisions	2,491.08^a	2,474.65^a
Liabilities	—	—
Non-current liabilities	2,516^a	2,540.32^a
Financial liabilities	—	—
Lease liabilities	74.59^a	121.96^a
Trade payables	—	—
Total outstanding dues of micro enterprises and small enterprises	85.21^a	19.79^a
Total outstanding dues of creditors other than micro enterprises and small enterprises	6,997.27^a	6,234.31^a
Other financial liabilities	1,770.21^a	1,421.11^a
Current liabilities	—	—
Other current liabilities	715^a	531.31^a
Provisions	4,164.09^a	3,935.2^a
Current tax liabilities (net)	5,245.17^a	2,985.79^a
Current liabilities	19,051.55^a	15,249.46^a
Total liabilities	21,567.55^a	17,789.78^a
Total equity and liabilities	41,080.66^a	35,566.18^a

Verified Sources Behind GlaxoSmithKline Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GlaxoSmithKline Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. GlaxoSmithKline Pharmaceuticals's Annual Report 2025

Trace every data point back to GlaxoSmithKline Pharmaceuticals’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

GlaxoSmithKline Pharmaceuticals Ltd

Financial Statements of GlaxoSmithKline Pharmaceuticals

Verified Sources Behind GlaxoSmithKline Pharmaceuticals’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Max Healthcare Institute Ltd

Abbott India Ltd

Piramal Pharma Ltd

Emcure Pharmaceuticals Ltd

Natco Pharma Ltd

Fortis Healthcare Ltd